---
title: "Allopregnanolone alters network activity and promotes positive affective states"
excerpt: "Neurosteroid modulation of oscillatory states in the amygdala explains the long-lasting antidepressant effects of allopregnanolone and its analogs."
header:
    teaser: /assets/images/allo_graphical_abstract.jpg
external_url: https://doi.org/10.1016/j.biopsych.2021.07.017
layout: single
author_profile: true
date: 2022-02-01
---

<a href="https://doi.org/10.1016/j.biopsych.2021.07.017">
  <img src="/assets/images/allo_graphical_abstract.jpg" alt="allo" style="max-width: 600px; margin-bottom: 1rem; border-radius: 6px;">
</a>

**Summary**
Brexanolone (allopregnanolone) is FDA-approved for postpartum depression but its long-lasting antidepressant effects are not fully understood. Using EEG, fMRI, and behavioral testing, we show allopregnanolone alters oscillatory states in the basolateral amygdala (BLA) via Î´-GABA<sub>A</sub> receptors. These changes modulate behavioral states through unique mechanisms not shared by benzodiazepines.

**Key findings:**
- Allopregnanolone and analogs modulate network oscillations across species.
- Î´-GABA<sub>A</sub> receptors in the BLA are key mediators.
- Neurosteroid effects differ from traditional anxiolytics.
- Optogenetic manipulation of BLA oscillatory states increases negative affective states.

**Authors:**  Pantelis Antonoudiou, Phillip L. W. Colmers, Najah L. Walton, Grant L. Weiss, Anne C. Smith, David P. Nguyen, Mike Lewis, Michael C. Quirk, Lea Barros, Laverne C. Melon, Jamie L. Maguire

ðŸ”— [Read the paper (Biological Psychiatry)](https://doi.org/10.1016/j.biopsych.2021.07.017)
ðŸ“– *Available Open Access on* **PMC**: [PMCID: PMC8714669](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714669/)
